Immunohistochemistry assays were performed to analyze the protein expression and subcellular localization of HMGN2 in a cohort of 60 paraffin-embedded archived glioma tissue samples (16 grade 2 glioma, 18 grade 3 glioma, and 26 grade 4 glioma). Here, HMGN2 is linked to central nervous system cancer.